HSC Section 8_April 2017

Selected Section Materials by Topic

Schilling C, Stoeckli SJ, Haerle SK, et al. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J Cancer . 2015; 51(18):2777-2784. EBM level 2

Quality of Life

Reeve BB, Cai J, Zhang H, et al. Factors that impact health-related quality of life over time for individuals with head and neck cancer. Laryngoscope . 2016; 126(12):2718-2725. EBM level 4

Rettig EM, D'Souza G, Thompson CB, et al. Health-related quality of life before and after head and neck squamous cell carcinoma: analysis of the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage. Cancer . 2016; 122(12):1861-1870. EBM level 4 Sethugavalar B, Teo MT, Buchan C, et al. Impact of prophylactic gastrostomy or reactive NG tube upon patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: a matched pair analysis. Oral Oncol . 2016; 59:80-85. EBM level 3

Treatment Modalities Update: Robotic Surgery

Choby GW, Kim J, Ling DC, et al. Transoral robotic surgery alone for oropharyngeal cancer: quality-of- life outcomes. JAMA Otolaryngol Head Neck Surg . 2015; 141(6):499-504. EBM level 4

Kumar B, Cipolla MJ, Old MO, et al. Surgical management of oropharyngeal squamous cell carcinoma: survival and functional outcomes. Head Neck . 2016; 38 Suppl 1:E1794-1802. EBM level 3

Treatment Modalities Update: Immunotherapy

Andtbacka RH, Agarwala SS, Ollila DW, et al. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. Head Neck . 2016; 38(12):1752- 1758. EBM level 2 Yimaer W, Abudouyimu A, Tian Y, et al. Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled trials. Onco Targets Ther . 2016; 9:1167-1173. EBM level 1

Inflammatory: GERD Role in Cancer Development and Prevention

Busch EL, Zevallos JP, Olshan AF. Gastroesophageal reflux disease and odds of head and neck squamous cell carcinoma in North Carolina. Laryngoscope . 2016; 126(5):1091-1096. EBM level 3

Papagerakis S, Bellile E, Peterson LA, et al. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma. Cancer Prev Res (Phila) . 2014; 7(12):1258-1269. EBM level 3

Section 8: Otology and Neurotology

Migraine and Vertigo

Chang TP, Lin YW, Sung PY, et al. Benign paroxysmal positional vertigo after dental procedures: a population-based case-control study. PLOS One . 2016; 11(4):e0153092. EBM level 3

I - 15